Cortellis

@Cortellis

Cortellis, a Analytics solution, unlocks hidden insights in data to accelerate life sciences innovation.

Vrijeme pridruživanja: srpanj 2011.

Tweetovi

Blokirali ste korisnika/cu @Cortellis

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Cortellis

  1. 4. velj

    MENA regulators are looking to implement HTA to more efficiently evaluate healthcare interventions. Gain insights into the current state of HTA in MENA. Read the article: 

    Poništi
  2. 3. velj

    Access existing research to better guide your efforts with free access to Drug Discovery Intelligence, which includes drug pipelines, disease briefings, experimental pharmacology, pharmacokinetics, targets & more:

    Poništi
  3. 3. velj

    The buzz around the microbiome & its effects on human health has generated significant growth in research. But how can we harness insights from the vast amounts of data generated? Read the article to find out: 

    Poništi
  4. proslijedio/la je Tweet
    3. velj

    Clarivate's new resource center offers leading research from , breaking news from and complimentary access to Drug Discovery Intelligence for the latest on the evolving health crisis:

    Poništi
  5. 31. sij

    comes to close. Great presentations and hot topics discussed (Authorities future strategy, telematic projects, worksharing relevance or role of big data). Looking forward to 20th RAC!

    Poništi
  6. 31. sij

    Iteresting session at on How to handle digital compound? To highlight vision presented “EMA is interested and open to innovation and engagement early and throughout clinical trial endoint development”

    Poništi
  7. 30. sij

    New drug monograph on Zoliflodacin for the treatment of uncomplicated gonorrhea just published in Drugs of the Future. Check out the latest issue at

    Poništi
  8. 30. sij

    PharmaMar receives $200 million upfront payment from Jazz after expiration of Hart-Scott-Rodino waiting period for lurbinectedin license agreement signed in December 2019

    Poništi
  9. 30. sij

    Geat 1ºsession at where it has been highlighted that collaboration between regulators & industry is needed to get more integrated approach for multiple jurisdictions (as a reference product for several jurisdictions), this should be a principal to respond to globalization.

    Poništi
  10. 30. sij

    Cortellis is Live at in Amsterdam

    Poništi
  11. 29. sij

    comes to close. Exellent and lively discussions have been held between regulators and industry representatives regarding current hot topics as the role of big data in patient safety, worksharing importance to get harmonization of requirements or latest inspection trends.

    Poništi
  12. 29. sij

    As regards communication of safety information: How can end user experience (physicians and patients) be improved? This was a common topic in some sessions of the

    Poništi
  13. 29. sij

    Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm, new monograph available in Drugs of Today. Check out the latest issue at

    Poništi
  14. 29. sij

    Interesting session at on highlights and overview on what it has been learned from EudraVigilance pilot

    Poništi
  15. 29. sij

    Cortellis is Live at

    Poništi
  16. 28. sij

    Get up to speed on the latest regulatory developments. Discover the key trends and changes that pharma companies should anticipate for a successful 2020. Register for the January 29th webinar:

    Poništi
  17. 23. sij

    Regenerative Medicine of Latin America to sell Zhittya Genesis Medicine's biological drugs in Latin American market

    Poništi
  18. 21. sij

    Delivering extended value across the entire drug, device and innovation lifecycle. That’s the impact of ’s pending acquisition:

    Poništi
  19. 21. sij

    Attending the 19th Regulatory and Scientific Affairs Conference We'll report on the regulators, industry experts and hear about the new EU political landscape - how will it impact the pharmaceutical regulatory environment?

    Poništi
  20. 21. sij

    Looking forward to reporting from in Amsterdam. How will you Hear from regulators and leading experts talk about challenges and opportunities in Pharmacovigilance for 2020

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·